Ken Shimada
Impact in
- Oncology top 5%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Drug Transport and Resistance Mechanisms
- Pancreatic and Hepatic Oncology Research
- Gastroenterology top 5%
- Gastrointestinal Tumor Research and Treatment
Papers in
- Oncology 54
- Colorectal Cancer Treatments and Studies 34
- Cancer Treatment and Pharmacology 14
- Pancreatic and Hepatic Oncology Research 7
-
- Gastric Cancer Management and Outcomes 23
- Lung Cancer Treatments and Mutations 10
- Co-authors
- Jaffer A. Ajani (3 shared papers)Hideki Tanzawa (10 shared papers)Katsuhiro Uzawa (8 shared papers)Yasutsuna Sasaki (11 shared papers)Atsushi Kasamatsu (5 shared papers)Masashi Shiiba (7 shared papers)Masato Nakamura (13 shared papers)Yu Sunakawa (16 shared papers)
- Journals
- Journal of Clinical Oncology (16 papers)Cancer Chemotherapy and Pharmacology (8 papers)Investigational New Drugs (4 papers)Annals of Oncology (3 papers)Gastric Cancer (3 papers)
- Partner nations
- JapanUnited StatesChina
In The Last Decade
Ken Shimada
98 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 96
- Oncology 562
- Gastroenterology 60
- Pulmonary and Respiratory Medicine 281
- Obstetrics and Gynecology 60
- Hepatology 55
Countries citing papers authored by Ken Shimada
This map shows the geographic impact of Ken Shimada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Shimada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Shimada more than expected).
Fields of papers citing papers by Ken Shimada
This network shows the impact of papers produced by Ken Shimada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Shimada. The network helps show where Ken Shimada may publish in the future.
Co-authors
The 25 scholars most cited alongside Ken Shimada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 104 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 195 | |
| 2 | 2014 | 61 | |
| 3 | 2005 | 58 | |
| 4 | 2015 | 56 | |
| 5 | 1999 | 56 | |
| 6 | 2013 | 49 | |
| 7 | 2001 | 45 | |
| 8 | 2004 | 40 | |
| 9 | 2015 | 38 | |
| 10 | 2016 | 37 | |
| 11 | 2004 | 36 | |
| 12 | 1995 | 36 | |
| 13 | 2017 | 32 | |
| 14 | 2015 | 32 | |
| 15 | 2005 | 30 | |
| 16 | 2002 | 28 | |
| 17 | 2009 | 27 | |
| 18 | 2015 | 27 | |
| 19 | 2019 | 26 | |
| 20 | 2014 | 25 |
About Ken Shimada
Ken Shimada is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Molecular Biology and Pathology and Forensic Medicine, having authored 104 papers that have together received 1.4k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (34 papers), Gastric Cancer Management and Outcomes (23 papers), Cancer Treatment and Pharmacology (14 papers), Lung Cancer Treatments and Mutations (10 papers), Pancreatic and Hepatic Oncology Research (7 papers), Gastrointestinal Tumor Research and Treatment (4 papers), Nausea and vomiting management (4 papers) and Neuroendocrine Tumor Research Advances (4 papers). The work is most often cited by research in Oncology (562 citations), Gastroenterology (60 citations), Pulmonary and Respiratory Medicine (281 citations), Obstetrics and Gynecology (60 citations) and Hepatology (55 citations). Ken Shimada has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Jaffer A. Ajani, Hideki Tanzawa, Katsuhiro Uzawa, Yasutsuna Sasaki, Atsushi Kasamatsu, Masashi Shiiba, Masato Nakamura, Yu Sunakawa, Yasuhide Yamada and Isamu Ohashi. Their work appears in journals such as Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology, Investigational New Drugs, Annals of Oncology and Gastric Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.